Evidence map›Paper›PMID 41084847›Full record

ReviewNanomedicine (London, England)2025

Nanotechnology based approaches to the treatment of schistosomiasis: current status and future perspectives.

José Márcio Fernandes da Silva, Dominique Mesquita E Silva, Josué de Moraes, Guilherme Diniz Tavares, Ademar A da Silva Filho

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Nanomedicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

José Márcio Fernandes da SilvaFaculdade de Farmácia, Departamento de Ciências Farmacêuticas, Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil.
Dominique Mesquita E SilvaFaculdade de Farmácia, Departamento de Ciências Farmacêuticas, Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil.
Josué de MoraesNúcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, Brazil.ORCID 0000-0003-1766-7031
Guilherme Diniz TavaresFaculdade de Farmácia, Departamento de Ciências Farmacêuticas, Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil.ORCID 0000-0001-6276-0994
Ademar A da Silva FilhoFaculdade de Farmácia, Departamento de Ciências Farmacêuticas, Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil.ORCID 0000-0002-9096-1336

Funding

CNPq, CAPES, FAPESPFAPEMIG
6 · The paper itself

Abstract

Schistosomiasis is the most impactful Neglected Tropical Diseases (NTDs) affecting over 240 million people in impoverished tropical and subtropical regions across 78 countries. Despite significant advances in research, praziquantel (PZQ) remains the only available treatment, raising concerns about the emergence of tolerant or resistant

Indexed as

NanotechnologySchistosomiasisAnimalsDrug Delivery SystemsHumansLiposomesNanomedicineNanoparticlesPraziquantelSchistosomaLiposomesPraziquantelAntischistosomalnanoparticlesnanotechnologynatural productspraziquantelSchistosoma

Identifiers

PMID41084847
PMCPMC12622349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.